Filter
436
Filtered Results: 436
Text search:
pharmacokinetics
Featured
Recommendations
53
New Publications
86
Language
Document type
No document type
230
Guidelines
98
Studies & Reports
66
Manuals
19
Training Material
8
Fact sheets
7
Strategic & Response Plan
6
Situation Updates
1
Online Courses
1
Countries / Regions
India
24
Global
13
Ethiopia
11
Kenya
8
Latin America and the Carribbean
8
South Africa
7
Russia
7
Africa
6
Western and Central Europe
6
Sierra Leone
5
Zimbabwe
5
Germany
5
Bangladesh
5
Uganda
5
Zambia
5
Ghana
4
Eastern Europe
4
Brazil
4
Namibia
4
Ukraine
3
Rwanda
3
Nigeria
3
Tanzania
3
South–East Asia Region
3
East and Southern Africa
3
Argentina
3
Liberia
3
Thailand
2
Cameroon
2
Cambodia
2
West and Central Africa
2
Paraguay
2
Eswatini/ Swaziland
2
Nepal
1
Lesotho
1
Australia
1
Syria
1
Burkina Faso
1
Philippines
1
Mozambique
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
North America
1
Denmark
1
Sudan
1
Angola
1
Botswana
1
South Sudan
1
Indonesia
1
Authors & Publishers
Publication Years
Category
Countries
119
Clinical Guidelines
101
Public Health
19
Women & Child Health
17
Capacity Building
4
Pharmacy & Technologies
3
Key Resources
2
Toolboxes
TB
69
HIV
54
AMR
37
Pharmacy
26
Mental Health
25
NTDs
23
COVID-19
17
Ebola & Marburg
12
Malaria
12
NCDs
10
Refugee
6
Planetary Health
6
Rapid Response
5
Caregiver
5
Disability
3
Polio
2
Global Health Education
2
Natural Hazards
1
Conflict
1
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
doi: https://doi.org/10.1101/2020.11.30.20236570
Pre-Print Article
Recommendations for a public health approach
2010 revision
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
Essential Medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy, safety and comparative cost-effectiveness. This edition of the Essential Medicines List (EML) 2017 for Ghana has been deriv...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Effectiveness of Education and an Antibiotic-Control Program in a Tertiary Care Hospital in Thailand
Overuse of antimicrobial agents occurs globally in both community and hospital settings. Misuse of antibiotics can lead to a variety of adverse outcomes, including the development of antimicrobial resistanceand increased cost of hospitalization. This issuehas been particularly problematic in de...
HIV & AIDS Treatment in Practice No. 198
